Injection Frequency and Steady State

For a given weekly dose, more frequent injections produce a smoother concentration curve with lower peaks and higher troughs. That is one of the most actionable insights in pharmacokinetics, and it applies whether you are on TRT or running a heavier cycle. The short version: split your weekly testosterone dose into at least two injections for long esters. The math is clear on this.

The peak-to-trough ratio

Once-weekly Testosterone Cypionate produces a large swing: a high peak in the first two days after injection, and a low trough right before the next dose. That swing is called the peak-to-trough ratio. Twice-weekly dosing at the same total weekly amount roughly halves the swing.

Why does the trough matter more than the peak? Because symptoms track the trough. A man whose trough total testosterone falls below the eugonadal range feels tired, flat, and low-libido in the 48 hours before his next shot, even if his peak is well above range. A man whose trough sits comfortably mid-range feels consistent.

This is the core argument for higher frequency. You are not raising the average level. You are squeezing the curve flatter so the lows are not so low.

Why it matters for side effects

The peak is where side effects live. High peaks drive aromatization (estradiol conversion), DHT conversion, and acne. A sharp peak means a sharp spike in estradiol and DHT a day or two after injection, which is why some men get post-injection acne and water retention on a once-weekly schedule that disappears when they split the dose.

Low troughs drive fatigue, low mood, and libido loss in the days before the next dose. The classic “I feel great for three days then crash” pattern on weekly testosterone is almost always a peak-to-trough problem, not a dose problem. The fix is frequency, not more milligrams.

Splitting the dose attacks both ends at once. Lower peaks mean less aromatization and fewer androgenic side effects. Higher troughs mean fewer crash days. Same total hormone, fewer problems.

Recommendations by ester half-life

Frequency should scale with ester half-life. Shorter esters clear faster, so the curve swings more for a given interval, and you need more frequent injections to keep it flat.

Propionate (half-life roughly 1 to 2 days): every other day at minimum, daily is smoother. The rapid clearance means a twice-weekly schedule produces wild swings.

Phenylpropionate (2 to 3 days): every 2 to 3 days. A Sustanon-style blend containing phenylpropionate and isocaproate smooths this somewhat.

Enanthate and Cypionate (roughly 5 to 7 days): twice a week is the practical sweet spot. Three times a week is marginally smoother and worth it if you are symptomatic at trough on twice-weekly.

Undecanoate (Nebido, roughly 34 days): dosed every 10 to 14 weeks by clinical protocol. Frequency on this ester is set by the formulation, not the user.

For Testosterone Enanthate, splitting 200 mg per week into two 100 mg injections (say Monday morning and Thursday evening) keeps the curve visibly flatter than a single 200 mg shot. Add a third injection (roughly 67 mg every two to three days) and the curve is nearly flat. The downside is purely logistical: more needle pokes.

Steady state

Regardless of frequency, it takes roughly 4 to 5 half-lives to reach steady state, the point where each dose adds the same amount that the prior dose has cleared. For cypionate and enanthate, that is about 4 to 5 weeks. For undecanoate, it is several months.

This is why “I don’t feel it yet at week 2” is normal and expected. The curve is still climbing toward its plateau. Adjusting your dose at week 2 based on symptoms is premature, because you are not yet at steady state. Draw bloodwork at week 6, not week 2.

Steady state also works in reverse. When you stop a long ester, it takes the same 4 to 5 half-lives to clear. This is why PCT timing matters and why coming off a long ester cold leaves you in a low-testosterone fog for weeks. See our article on tapering, cruising, and coming off for the clearance math.

The trade-off

More frequent injections mean more needle pokes, more supplies, and more schedule friction. For most men on long esters, twice-weekly is the right balance of smooth curve and manageable logistics. If you are injecting propionate, the trade-off forces itself: you accept more frequent injections or you accept a swingy curve.

Use the plotter to model your specific ester, dose, and frequency before committing. The chart tells you in seconds whether your chosen schedule stays inside the reference range or swings out of it.

FAQ

Does injecting more frequently mean I need less total testosterone? Not necessarily. Frequency flattens the curve but the weekly average stays similar for a given total dose. What changes is the swing: lower peaks, higher troughs. Some men find they need slightly less total testosterone once they split the dose, because the consistent level resolves symptoms that were driving them to push dose up.

Is every-other-day or daily dosing better than twice-weekly? For long esters like enanthate and cypionate, twice-weekly is enough for most people. Three times a week is marginally smoother. Daily dosing on long esters adds logistical burden without much curve benefit. For short esters like propionate, daily or every-other-day is required to keep the curve flat.

Why do I feel worse the day before my injection? That is the trough. Your circulating testosterone is at its lowest point in the cycle. Splitting the dose raises the trough and removes that crash day. If splitting to twice-weekly does not fix it, try three times a week.

How long until I feel a frequency change? For long esters, expect 4 to 6 weeks to see the new steady state in bloodwork. Symptom changes may appear sooner as the curve flattens, but labs are the real signal. Draw at trough on the new schedule.

Can I micro-dose with an insulin syringe to inject more frequently? Subcutaneous injection with insulin syringes is a common TRT approach that allows frequent dosing with less tissue trauma. Absorption is slightly slower than intramuscular but the curve is comparable for long esters. This is a clinical discussion with your provider, not a universal protocol.

Sources

• Snyder PJ, et al. Effects of testosterone replacement in older men. New England Journal of Medicine. 2016. PMID: 26810045.
• Cui Y, et al. Pharmacokinetics of testosterone cypionate after intramuscular injection. Asian Journal of Andrology. PubMed PMID: 23503675.
• Palmert MR, et al. Variability in ester release and steady-state attainment. Journal of Clinical Endocrinology and Metabolism.
• Morgentaler A, et al. Testosterone therapy in men with androgen deficiency. Endocrine Society Clinical Practice Guideline. 2018.